Houlihan WJ - Search Results

1

γ-Secretase Partitioning into Lipid Bilayers Remodels Membrane Microdomains after Direct Insertion.

Barros M, Houlihan WJ, Paresi CJ, Brendel M, Rynearson KD, Lee CW, Prikhodko O, Cregger C, Chang G, Wagner SL, Gilchrist ML, Li YM. Barros M, et al. Among authors: houlihan wj. Langmuir. 2020 Jun 16;36(23):6569-6579. doi: 10.1021/acs.langmuir.0c01178. Epub 2020 Jun 4. Langmuir. 2020. PMID: 32432881 Free PMC article.

2

Assessment of mazindane, a pro-drug form of mazindol, in assays used to define cocaine treatment agents.

Houlihan WJ, Kelly L. Houlihan WJ, et al. Eur J Pharmacol. 2003 Jan 5;458(3):263-73. doi: 10.1016/s0014-2999(02)02791-7. Eur J Pharmacol. 2003. PMID: 12504782

3

Three-dimensional quantitative structure-activity relationships of mazindol analogues at the dopamine transporter.

Kulkarni SS, Newman AH, Houlihan WJ. Kulkarni SS, et al. Among authors: houlihan wj. J Med Chem. 2002 Sep 12;45(19):4119-27. doi: 10.1021/jm0102093. J Med Chem. 2002. PMID: 12213055

4

Benzo- and cyclohexanomazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.

Houlihan WJ, Ahmad UF, Koletar J, Kelly L, Brand L, Kopajtic TA. Houlihan WJ, et al. J Med Chem. 2002 Sep 12;45(19):4110-8. doi: 10.1021/jm010301z. J Med Chem. 2002. PMID: 12213054

5

Mazindol analogues as potential inhibitors of the cocaine binding site at the dopamine transporter.

Houlihan WJ, Kelly L, Pankuch J, Koletar J, Brand L, Janowsky A, Kopajtic TA. Houlihan WJ, et al. J Med Chem. 2002 Sep 12;45(19):4097-109. doi: 10.1021/jm010302r. J Med Chem. 2002. PMID: 12213053

6

High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol.

Barker EL, Perlman MA, Adkins EM, Houlihan WJ, Pristupa ZB, Niznik HB, Blakely RD. Barker EL, et al. Among authors: houlihan wj. J Biol Chem. 1998 Jul 31;273(31):19459-68. doi: 10.1074/jbc.273.31.19459. J Biol Chem. 1998. PMID: 9677366 Free article.

7

Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.

Houlihan WJ, Boja JW, Parrino VA, Kopajtic TA, Kuhar MJ. Houlihan WJ, et al. J Med Chem. 1996 Dec 6;39(25):4935-41. doi: 10.1021/jm960288w. J Med Chem. 1996. PMID: 8960553

8

Antitumor activity of the R- and S-enantiomers of RS-2-[[hydroxy[[2-[ (octadecyloxy)methyl]tetrahydrofuran-2-yl]methoxy]-phosphinyl]oxy]-N, N,N,-trimethylethylaminium hydroxide inner salt.

Houlihan WJ, Prasad K, Underwood R, Repic O, Munder PG. Houlihan WJ, et al. J Med Chem. 1996 Jan 19;39(2):605-8. doi: 10.1021/jm950072e. J Med Chem. 1996. PMID: 8558533

9

Preclinical pharmacology and possible mechanism of action of the novel antitumor agent 5-(4'-piperidinomethylphenyl)-2,3-dihydroimidazo [2,1-a]isoquinoline.

Houlihan WJ, Munder PG, Handley DA, Nemecek GA. Houlihan WJ, et al. Arzneimittelforschung. 1995 Oct;45(10):1133-7. Arzneimittelforschung. 1995. PMID: 8595076

10

Phospholipid antitumor agents.

Houlihan WJ, Lohmeyer M, Workman P, Cheon SH. Houlihan WJ, et al. Med Res Rev. 1995 May;15(3):157-223. doi: 10.1002/med.2610150302. Med Res Rev. 1995. PMID: 7658750 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page